ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FDBK Feedback Plc

82.50
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 82.50 80.00 85.00 82.50 82.50 82.50 10,046 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -3.77 11M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 82.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £11 million. Feedback has a price to earnings ratio (PE ratio) of -3.77.

Feedback Share Discussion Threads

Showing 14126 to 14149 of 14825 messages
Chat Pages: Latest  569  568  567  566  565  564  563  562  561  560  559  558  Older
DateSubjectAuthorDiscuss
13/2/2023
08:56
SP up another 10% in the first hour of trading.

Do you think it’s trying to tell us something? ;)

dibs61
12/2/2023
16:53
'Ctrl + F' then type 'Bleepa' in dropdown box. 6 references found - page 7 (4 refs) & 28 (2 refs).
lr2
12/2/2023
16:37
Help me out LR2 while I watch England stumble to a victory over the mighty Azzurri, where exactly?
ducatiman
12/2/2023
16:31
Courtesy of Vascular over on the other place. Yorkshire & Humber AHSN - Bleepa gets a mention.
lr2
12/2/2023
16:01
As we have known for some time Ged, the clinicians love it. Getting their management to pay for it has been the issue.
It looks, however, that this is about to change.

ducatiman
12/2/2023
12:08
Checking the website today there seem to be a number of updates. This was in the 'News' section last Monday. For anyone looking in it summarises what Bleepa does. The link also includes some benefits.

"Bleepa is simple to deploy, cost-effective and aids existing workflows, without requiring teams to reconfigure the way that they work.

A former NHS Trust Chief Executive puts it simply: “Having ready, secure access to relevant data around a patient’s step-down care means you can accelerate discharge planning, minimise risks to patient safety and reduce costly, avoidable readmissions.”

Thousands of care professionals have already seen the benefit that Bleepa can have in their ability to work seamlessly across care settings, ensure the highest levels of safety and care for their patients, and efficiently manage care pathways.

As the only UKCA accredited medical app that allows you to share, annotate and discuss clinical grade images on a mobile device, Bleepa can help you to make the most of your team’s capacity to provide high-quality, networked care."

ged5
11/2/2023
12:08
Looking at some of the statements over on LSE, it needs pointing out that the options DO NOT EXPIRE in May 2025. They expire for Tom and Anesh in 2030 and for Rory in 2032.

The share price needs to reach £2.40 by may 2025 for one third to vest, £3.72 for another third to vest and £6.00 for the final 139,744 options to vest.

When the price has gone above £2.40 TO could convert 139,744 options at £1.40. It would only cost him £195,641. He has until 31st May 2030 to save up.

There are a total of 1,086,703 share options. 726,186 subject to the above conditions.

But of course I'm only posting what you already know because you'll all have read the annual report pages 44 and 72 and RNS 23rd February.





The cheapest options for TO are £2.18. With the price at £1.65 perhaps he should get some now. Seems like a bargain for him. No advice intended. I'm not qualified to give it.

ged5
10/2/2023
18:03
LR210 Feb '23 - 14:45 - 10703 of 10710

Red Leg Rum, Yump. Best you can find on the supermarket shelves.

Rum punch is a bit of a weakness. I'd like to be around long enough to see FDBK succeed, so I might give that a miss !

yump
10/2/2023
16:15
Some easy listening for Fdbk shareholders over the weekend.
ducatiman
10/2/2023
16:05
Auto bid 163.50 and still in size.
ducatiman
10/2/2023
15:18
Interesting read the medical technology strategy. Come on Mr Barclay get Bleepa rolled out nationwide. Right time/place certainly applies here.
petekand
10/2/2023
14:52
Brasso
You’ll have to be mumbling mad to sell any Feedback when the pipeline has groundbreaking news ready to churn out.
I’ll stick with my prediction of nearer to £3 by the time we see the QVH RNS and that will be the key which alerts the wider market.

petekand
10/2/2023
14:47
I'm holdong for 2000p Duc.
lr2
10/2/2023
14:46
I think 200 easy next week with or without news.
ducatiman
10/2/2023
14:45
Red Leg Rum, Yump. Best you can find on the supermarket shelves.
lr2
10/2/2023
14:34
Crikey I feel like having a drink to celebrate !
yump
10/2/2023
14:02
Contracts news in the next 6-8 weeks should cover 200p quite well.
lr2
10/2/2023
13:42
Its hard to see why anyone would sell here with a large part of the market cap. covered by cash. Looks like a safe bet for 200p in the next 4 - 6 weeks.
brasso3
10/2/2023
10:50
Yes rag, I wonder where they got that from 🤔.
ducatiman
10/2/2023
10:11
A few days ago The dept of health and social care published Medical Technology Strategyhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1134006/medical-technology-strategy.pdfDemand for diagnostics is continuing to rise and waiting lists have increased following the reduction in availability of services during the pandemic, so it is vital that we continue to improve and expand our diagnostic capacity. In tackling these challenges, we have an opportunity to move to a more patient-centric model of care, and to better connect ourworld-leading life sciences sector with the NHS to transform elective diagnostics with the latest technologies.One of Toms favourite phrases is - Patient centric care model.
ragnarr
08/2/2023
23:28
Tom explains how Bleepa compliments Qure.ai and makes it into a much more powerful tool. He also says they are looking at projects together within the NHS.
Qure.ai is gaining significant global awareness thanks to its artificial intelligence software and Bleepa could do very well clinging onto their coat.
Tom is clearly in stealth mode and a lot more is going on than meets the eye.
Solid price action so far but the market cap is still only £21 million and with cash held making up almost 40 percent of the value. It looks as though traction is coming through with the CDCs so that value can literally go through the roof.
The new share structure and a limited free float of just a few million shares will certainly generate a major move at some point of the cycle.
All in all a very mature, confident presentation from a young man who definitely understands his onions.

petekand
08/2/2023
20:55
Thanks SSB, looking for much more over next couple of years.
lr2
08/2/2023
20:35
Well done friends.

Nice breakout.

BWTFDIK

sideshowbull
08/2/2023
19:48
Hundreds of thousands more patients to benefit from major NHS surgical capacity boosthttps://www.england.nhs.uk/2023/02/hundreds-of-thousands-more-patients-to-benefit-from-major-nhs-surgical-capacity-boost/
ragnarr
Chat Pages: Latest  569  568  567  566  565  564  563  562  561  560  559  558  Older

Your Recent History

Delayed Upgrade Clock